Main Details Contact Details
New Registration
 
Please provide a minimum of 2 names to whom all samples and correspondence should be addressed. Use the Contact Details tab to add more

 
      Default Contact   Trial Contact
  Title:    
  Forename(s):    
  Surname:    
  Email:    
  Tel No:    
  Fax No:    
  Department:    
  Hospital:    
  Street:    
  District:    
  Town/City:    
  Postcode:    
  Country:    
  Notify contact of genetic trial and report issues:    
  Currency:  
   
  Order Number:  
   
We would like to join the following programmes. Please tick as appropriate
       
  Leukaemia Immunophenotyping and Diagnostic Interpretation    
  Leukaemia Diagnostic Interpretation (Part 2 Institute)    
  Leukaemia Diagnostic Interpretation (Part 2 Individual)    
  Immune Monitoring  
  CD34+ Stem Cell Enumeration    
  Low Level Leucocyte Enumeration  
  Minimal Residual Disease for ALL by Flow Cytometry    
  JAK2 p.Val617Phe (V617F) Mutation Status    
  BCR-ABL1 Major Quantification    
  Post-Stem Cell Transplant Chimerism Monitoring    
  IgH/TCR Clonality Status    
  FLT3 Mutation Status    
  NPM1 Mutation Status    
  BCR-ABL1 Kinase Domain Mutation Status (Not Accredited)    
  BRAF p.Val600Glu (V600E) Mutation Status for Hairy Cell Leukaemia    
  KIT p.Asp816Val (D816V) Mutation Status for Mast Cell Disease    
  Paediatric Acute Leukaemia Translocations    
  Chronic Lymphocytic Leukaemia Gene Panels (Not Accredited)    
  BCR-ABL1 Minor Quantification (Not Accredited)    
  Immune Monitoring (AlternativeTechnologies)  
  Minimal Residual Disease for CLL by Flow Cytometry (Not Accredited)    
  Haematological Malignancy Bone Marrow Aspirate Assessment (Not Accredited)    
  Minimal Residual Disease for AML by Flow Cytometry (Not Accredited)    
  BCR-ABL1 and AML Translocation Identification    
  Paroxysmal Nocturnal Haemoglobinuria    
  Acute Myeloid Leukaemia and Myelodysplastic Syndrome Gene Panels (Not Accredited)    
  Myeloproliferative Neoplasms Gene Panels (Not Accredited)    
  Cerebrospinal Fluid (CSF) Immunophenotyping (Not Accredited)    
  Minimal Residual Disease for Plasma Cell Myeloma by Flow Cytometry (Not Accredited)    
  Lymphoplasmacytic Lymphoma / Waldenstrom Macroglobulinaemia (Not Accredited)    
 
 
       All contact details provided to UK NEQAS for Leucocyte Immunophenotyping, directly or through your distributor, will be used for the purposes of providing EQA Services. UK NEQAS for Leucocyte Immunophenotyping has the right to keep contact names in our secure databases for medico-legal purposes and cannot be removed. Do not submit any individuals contact details unless you have their express permission to do so.
            
Email addresses may also be used by UK NEQAS for Leucocyte Immunophenotyping for contacting participants regarding new programmes, pathology related matters and questionnaires. If you wish for your email addresses to be used for these purposes please check this option.
            
Your details will also be shared with other members of the UK NEQAS consortium for the purposes of marketing. To ensure that you receive UK NEQAS consortium communications, please click on the check box to opt-in. Please note if you do not choose to opt in then you will miss out on information and updates regarding the UK NEQAS consortium.